The Role of Emerging Therapeutics to Reduce Impairment and Improve Quality of Life for Patients With Early Alzheimer's Disease
WebcastFaculty
OVERVIEW
The Role of Emerging Therapeutics to Reduce Impairment and Improve Quality of Life for Patients With Early Alzheimer’s Disease is organized by Academic CME and will be held during Aug 28, 2017 - Aug 27, 2018.
The target audience for this medical event is Neurologists, primary care physicians, nurse practitioners, nurses and other healthcare professionals who care for patients with Alzheimer’s disease. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Discuss the pathophysiology of Alzheimer’s disease, including disease course, signs and symptoms
• Analyze clinical trial data for emerging therapeutics for the treatment of Alzheimer’s disease as presented at AAIC 2017
• Develop optimal strategies to create patient-specific treatment plans for the healthcare team to improve outcomes and the overall quality of life for patients with Alzheimer’s disease
Additional details will be posted as soon as they are available.
The target audience for this medical event is Neurologists, primary care physicians, nurse practitioners, nurses and other healthcare professionals who care for patients with Alzheimer’s disease. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Discuss the pathophysiology of Alzheimer’s disease, including disease course, signs and symptoms
• Analyze clinical trial data for emerging therapeutics for the treatment of Alzheimer’s disease as presented at AAIC 2017
• Develop optimal strategies to create patient-specific treatment plans for the healthcare team to improve outcomes and the overall quality of life for patients with Alzheimer’s disease
Additional details will be posted as soon as they are available.
SPECIALITIES
Neurology
Quick Links